Kriegsmann, K., Cremer, M., Kriegsmann, M., Ho, A. D., & Witzens-Harig, M. (2017). Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma. BMC cancer, 17, . https://doi.org/10.1186/s12885-017-3332-3
Chicago Style (17th ed.) CitationKriegsmann, Katharina, Martin Cremer, Mark Kriegsmann, Anthony Dick Ho, and Mathias Witzens-Harig. "Addition of Rituximab to CHOP-like Chemotherapy in First Line Treatment of Primary Mediastinal B-cell Lymphoma." BMC Cancer 17 (2017). https://doi.org/10.1186/s12885-017-3332-3.
MLA (9th ed.) CitationKriegsmann, Katharina, et al. "Addition of Rituximab to CHOP-like Chemotherapy in First Line Treatment of Primary Mediastinal B-cell Lymphoma." BMC Cancer, vol. 17, 2017, https://doi.org/10.1186/s12885-017-3332-3.